IFN-β induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Oncogene

• Publication date

  2000-07-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1203670PMID 10918594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of the p 38 Mitogen-activated Protein Kinase by Type I Interferons

  1999influential reference
• Bcl-2 overexpression results in reciprocal downregulation of Bcl-XL and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis

  1999cited by this paper
• Acquired Constitutive Expression of Interferon beta after Gene Transduction Enhances Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocyte Activity by a RANTES-Dependent Mechanism

  1999cited by this paper
• Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation

  1999cited by this paper
• Transcriptional regulation of the p21((WAF1/CIP1)) gene.

  1999cited by this paper
• Activation of the Jak-Stat Pathway in Cells That Exhibit Selective Sensitivity to the Antiviral Effects of IFN-beta Compared with IFN-alpha

  1999influential reference
• Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity

  1999cited by this paper
• Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases*

  1999cited by this paper
• Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.

  1999cited by this paper
• p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons

  1999influential reference
• Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial.

  1999cited by this paper
• Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemia.

  1998cited by this paper
• The role of interferon regulatory factors in the interferon system and cell growth control.

  1998influential reference
• Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.

  1998cited by this paper
• Differential Use of the βL Subunit of the Type I Interferon (IFN) Receptor Determines Signaling Specificity for IFNα2 and IFNβ*

  1998influential reference
• Differences in Activity between α and β Type I Interferons Explored by Mutational Analysis*

  1998influential reference
• Bcl-2 family proteins

  1998cited by this paper
• Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients.

  1998cited by this paper
• How cells respond to interferons.

  1998cited by this paper
• The regulation of D2 dopamine receptor expression

  1998cited by this paper
• Expression of type I interferon receptor in solid tumors of childhood.

  1997cited by this paper
• Caspases: Intracellular Minireview Signaling by Proteolysis

  1997cited by this paper
• Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins

  1997cited by this paper
• EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.

  1997cited by this paper
• Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.

  1997cited by this paper
• The growing family of interferon regulatory factors.

  1997cited by this paper
• IFNα induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells

  1997cited by this paper
• The state of the STATs: recent developments in the study of signal transduction to the nucleus.

  1997cited by this paper
• IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.

  1997cited by this paper
• How does interferon exert its cell growth inhibitory effect?

  1997cited by this paper
• Interferons in Precancer and Cancer Prevention: Where Are We?

  1996cited by this paper
• EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.

  1996cited by this paper
• Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1

  1996cited by this paper
• The Human Type I Interferon Receptor

  1996influential reference
• The type-I interferon receptor. The long and short of it.

  1996cited by this paper
• Essential and non‐redundant roles of p48 (ISGF3γ) and IRF‐1 in both type I and type II interferon responses, as revealed by gene targeting studies

  1996cited by this paper
• Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage

  1996cited by this paper
• Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

  1996cited by this paper
• Requirement of serine phosphorylation for formation of STAT-promoter complexes.

  1995cited by this paper
• Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors.

  1995cited by this paper
• Triggering of the Human Interleukin-6 Gene by Interferon-γ and Tumor Necrosis Factor-α in Monocytic Cells Involves Cooperation between Interferon Regulatory Factor-1, NFκB, and Sp1 Transcription Factors (*)

  1995cited by this paper
• Transmembrane Signaling by the α Subunit of the Type I Interferon Receptor Is Essential for Activation of the Jak Kinases and the Transcriptional Factor ISGF3 (*)

  1995cited by this paper
• Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.

  1995cited by this paper
• An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes

  1995cited by this paper
• Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages

  1995cited by this paper
• Interferon-beta strong cytopathic effect on human papillomavirus type 16-immortalized HPK-IA cell line, unexpectedly not shared by interferon-alpha.

  1995cited by this paper
• DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma

  1994cited by this paper
• Cytokine therapeutics: lessons from interferon alpha.

  1994influential reference
• p53 mutations in human tumors with chimeric EWS/FLI/1 genes

  1994cited by this paper
• Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system

  1994cited by this paper
• The human interferon alpha/beta receptor: characterization and molecular cloning.

  1994cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

  1993cited by this paper
• Interferon-alpha in malignant and viral diseases. A review.

  1993cited by this paper
• Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours.

  1993cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.

  1993cited by this paper
• Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2

  1993cited by this paper
• A protein tyrosine kinase in the interferon alpha/beta signaling pathway.

  1992cited by this paper
• Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

  1992cited by this paper
• Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA.

  1990cited by this paper
• Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway

  1989cited by this paper
• Principles and Practice of Pediatric Oncology

  1989cited by this paper
• Molecular Cloning and Expression of the Human Interferon-y Receptor

  1988cited by this paper
• Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alpha.

  1988cited by this paper
• Molecular cloning and expression of the human interferon-gamma receptor.

  1988cited by this paper
• Interferon-responsive regulatory elements in the promoter of the human 2',5'-oligo(A) synthetase gene

  1987influential reference
• Interferons and their actions.

  1987cited by this paper
• Chromosomal translocations in Ewing's sarcoma.

  1983cited by this paper

• The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma

  2025cites this paper
• Roles of Interferon Regulatory Factor 1 in Tumor Progression and Regression: Two Sides of a Coin

  2024cites this paper
• Functional Significance of the C-Terminal Domain of Human Interferon Regulatory Factor-1 (IRF-1) in Gene Expression and Cell Cycle Regulation

  2024cites this paper
• The multiple roles of interferon regulatory factor family in health and disease

  2024cites this paper
• Mesenchymal Stem Cells Carrying IFN-α and IFN-β Overexpression Genes Inhibit Non-Small Cell Lung Cancer via the JAK/STAT Pathway

  2023cites this paper
• Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks

  2023cites this paper
• Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction

  2023cites this paper
• Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis

  2022cites this paper
• Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.

  2021cites this paper
• ATR inhibitor–induced CDK1-SPOP axis destabilizes PD-L1 and enhances cytotoxicity in prostate cancer

  2021cites this paper
• Type I and II interferons toward ideal vaccine and immunotherapy

  2021cites this paper
• Neurooncogenesis in the Development of Neuroectodermal Cancers

  2021cites this paper
• ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer

  2021cites this paper
• In cardiac fibroblasts, interferon-beta attenuates differentiation, collagen synthesis, and TGF-β1-induced collagen gel contraction.

  2020cites this paper
• Toll-like Receptors from the Perspective of Cancer Treatment

  2020cites this paper
• The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma

  2020cites this paper
• Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells

  2019cites this paper
• CD 80 + and CD 86 + B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy / tropical spastic paraparesis and multiple sclerosis

  2019cites this paper
• Chromatin Stability as a Target for Cancer Treatment

  2018cites this paper
• XAF1 forms a positive feedback loop with IRF-1 to drive apoptotic stress response and suppress tumorigenesis

  2018cites this paper
• Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response

  2018cites this paper
• Identifying Regulators from Multiple Types of Biological Data in Cancer

  2017cites this paper
• Retraction notice

  2017cites this paper
• IFN-β induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-α in PBMCs of Adult T-cell Leukemia/Lymphoma patients

  2017cites this paper
• Complement pathway amplifies caspase-11–dependent cell death and endotoxin-induced sepsis severity

  2016cites this paper
• Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.

  2015cites this paper
• A Canonical Correlation Analysis-Based Dynamic Bayesian Network Prior to Infer Gene Regulatory Networks from Multiple Types of Biological Data

  2015cites this paper
• The regulation role of interferon regulatory factor-1 gene and clinical relevance.

  2014cites this paper
• CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

  2014cites this paper
• Mechanisms of oncolytic activity of Newcastle disease virus strain AF2240 in human renal carcinoma cell line

  2014cites this paper
• possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

  2014cites this paper
• Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells

  2014cites this paper
• Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types

  2014cites this paper
• The Oncolytic Activity of Newcastle Disease Virus in Clear Cell Renal Carcinoma Cells in Normoxic and Hypoxic Conditions: The Interplay Between von Hippel-Lindau and Interferon-β Signaling

  2013cites this paper
• Type I interferons: ancient peptides with still under-discovered anti-cancer properties.

  2013cites this paper
• STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin?

  2013cites this paper
• Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis

  2012cites this paper
• USP18 establishes the transcriptional and anti-proliferative interferon α/β differential.

  2012cites this paper
• Sublytic C5b-9 Complexes Induce Apoptosis of Glomerular Mesangial Cells in Rats with Thy-1 Nephritis through Role of Interferon Regulatory Factor-1-dependent Caspase 8 Activation*

  2012cites this paper
• USP 18 establishes the transcriptional and antiproliferative interferon α / β differential

  2012cites this paper
• The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer

  2011cites this paper
• Understanding KSHV vIRF-2-cell interactions

  2011cites this paper
• Interactomics identifies novel regulators of the IRF-1 tumour suppressor protein

  2011cites this paper
• Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses

  2011influential citation
• Regulation of hepatocyte fate by interferon-γ.

  2011cites this paper
• Updating progress in sarcoma therapy with mTOR inhibitors.

  2011cites this paper
• IFNγ Restores Breast Cancer Sensitivity to Fulvestrant by Regulating STAT1, IFN Regulatory Factor 1, NF-κB, BCL2 Family Members, and Signaling to Caspase-Dependent Apoptosis

  2010influential citation
• Resistance to IFN-α–Induced Apoptosis Is Linked to a Loss of STAT2

  2010cites this paper
• p21WAF1 is involved in interferon-β- induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression in ovarian cancer

  2010cites this paper
• Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer

  2010cites this paper
• Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

  2009cites this paper
• Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.

  2009cites this paper
• Transcriptional Regulation of Apoptosis

  2009cites this paper
• IL-28 and IL-29 in Regulation of Antitumor Immune Response and Induction of Tumor Regression

  2009cites this paper
• RETRACTED: Effects of recombinant type I interferon therapy on human muscle diseases

  2009cites this paper
• Regulatory effects of IFN‐β on production of osteopontin and IL‐17 by CD4+ T Cells in MS

  2009cites this paper
• TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma

  2008cites this paper
• Effect of fibroblast growth factor-1 on the expression of early growth response-1 in human periodontal ligament cells.

  2008cites this paper
• Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling.

  2008cites this paper
• The IRF family transcription factors in immunity and oncogenesis.

  2008cites this paper
• The role of type I interferons in TLR responses

  2007cites this paper
• Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.

  2007cites this paper
• Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells

  2007cites this paper
• Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB

  2007cites this paper
• STAT1 as a key modulator of cell death.

  2007cites this paper
• Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.

  2007cites this paper
• Complex modulation of cell type-specific signaling in response to type I interferons.

  2006cites this paper
• IFN-alpha induces apoptosis of adipose tissue cells.

  2006cites this paper
• IR RF F- -1

  2006cites this paper
• Mechanisms of IRF-1 Induced Cancer Growth Inhibition

  2006cites this paper
• Monocyte 15-Lipoxygenase Expression Is Regulated by a Novel Cytosolic Signaling Complex with Protein Kinase C δ and Tyrosine-Phosphorylated Stat31

  2006cites this paper
• Tyrosine-Phosphorylated Stat 3 and δ Complex with Protein Kinase C Regulated by a Novel Cytosolic Signaling Monocyte 15-Lipoxygenase Expression Is

  2006cites this paper
• IFN-α induces apoptosis of adipose tissue cells

  2006cites this paper
• Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays.

  2006cites this paper
• A study of innate antiviral mechanisms using fish cell lines

  2006cites this paper
• Regulation of apoptosis and proliferation in Ewing's sarcoma—opportunities for targeted therapy

  2006cites this paper
• Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor‐1 knock‐out mice

  2005cites this paper
• Participation of Interferon-Alpha in Regulation of Apoptosis

  2005cites this paper
• Department of Oncology-Pathology, Cancer Center Karolinska,

  2005cites this paper
• Essential Role of STAT1 in Caspase-Independent Cell Death of Activated Macrophages through the p38 Mitogen-Activated Protein Kinase/STAT1/Reactive Oxygen Species Pathway

  2005cites this paper
• Therapeutic Implications of Interferon Regulatory Factor (IRF)-1 and IRF-2 in Diffusely Infiltrating Astrocytomas (DIA): Response to Interferon (IFN)-β in Glioblastoma Cells and Prognostic Value for DIA

  2005cites this paper
• Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma.

  2005cites this paper
• Alpha‐interferon and its effects on signal transduction pathways

  2005cites this paper
• Alternative Signaling Pathways Regulating Type I Interferon-Induced Apoptosis

  2005cites this paper
• Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.

  2005cites this paper
• Expression and in vitro cleavage activity of anti-caspase-7 hammerhead ribozymes.

  2004cites this paper
• Presence of Permanently Activated Signal Transducers and Activators of Transcription in Nuclear Interchromatin Granules of Unstimulated Mouse Oocytes and Preimplantation Embryos1

  2004cites this paper
• Role of Protein Kinase C Isoforms in the Regulation of Interleukin-13-induced 15-Lipoxygenase Gene Expression in Human Monocytes*

  2004cites this paper
• Two Different Mechanisms of Apoptosis Resistance Observed in Interferon-β Induced Apoptosis of Human Glioma Cells

  2004cites this paper
• Predominant contribution of IFN-beta expression to apoptosis induction in human uterine cervical fibroblast cells by influenza-virus infection.

  2004cites this paper
• Interferon Regulatory Factor-1 Mediates the Proapoptotic but Not Cell Cycle Arrest Effects of the Steroidal Antiestrogen ICI 182,780 (Faslodex, Fulvestrant)

  2004cites this paper
• IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo

  2004cites this paper
• Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors

  2004cites this paper
• Lymphocytes during Primary Response T + Proliferation and Death of Human CD 4 in the Balance between α A Dual Role of IFN-Susin and

  2004cites this paper
• A Dual Role of IFN-α in the Balance between Proliferation and Death of Human CD4+ T Lymphocytes during Primary Response1

  2004cites this paper
• Type I interferon and TNFα cooperate with type II interferon for TRAIL induction and triggering of apoptosis in SK-N-MC EWING tumor cells

  2004cites this paper
• Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells.

  2004cites this paper
• Abnormal levels of interferon-gamma receptors in active multiple sclerosis are normalized by IFN-beta therapy: implications for control of apoptosis.

  2004cites this paper
• Regulation of lymphoid cell apoptosis by Jaks and Stats.

  2004cites this paper
• Alpha-interferon and its effects on signalling pathways within cells.

  2004cites this paper